Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-08-19 5:47 pm Sale | 13D | ENZON PHARMACEUTICALS INC ENZN | ICAHN CARL C | 0 0.000% | -36,056,636 (Position Closed) | View |
2020-10-14 4:58 pm Purchase | 13D | ENZON PHARMACEUTICALS INC ENZN | ICAHN CARL C | 36,056,636 48.600% | 36,056,636 (New Position) | View |
2020-09-17 4:12 pm Unchanged | 13D | ENZON PHARMACEUTICALS INC ENZN | COUCHMAN JONATHAN | 7,851,454 17.800% | 0 (Unchanged) | View |
2020-09-01 5:01 pm Unchanged | 13D | ENZON PHARMACEUTICALS INC ENZN | ICAHN CARL C | 0 0.000% | 0 (Unchanged) | View |
2020-08-07 9:45 pm Unchanged | 13D | ENZON PHARMACEUTICALS INC ENZN | ICAHN CARL C | 0 0.000% | 0 (Unchanged) | View |
2020-08-05 4:59 pm Purchase | 13D | ENZON PHARMACEUTICALS INC ENZN | COUCHMAN JONATHAN | 7,851,454 17.800% | 506,292 (+6.89%) | View |
2020-04-16 5:00 pm Unchanged | 13D | ENZON PHARMACEUTICALS INC ENZN | COUCHMAN JONATHAN | 7,345,162 16.600% | 0 (Unchanged) | View |
2020-03-27 5:27 pm Purchase | 13G | ENZON PHARMACEUTICALS INC ENZN | COUCHMAN JONATHAN | 7,345,162 16.600% | 1,557,996 (+26.92%) | View |
2020-01-22 5:06 pm Purchase | 13G | ENZON PHARMACEUTICALS INC ENZN | POPLAR POINT CAPITAL MANAGEMENT LLC | 2,906,966 6.600% | 77,810 (+2.75%) | View |
2020-01-16 07:37 am Sale | 13G | ENZON PHARMACEUTICALS INC ENZN | HARPER ASSET MANAGEMENT LLC | 1,864,069 4.200% | -745,634 (-28.57%) | View |